In an informative upcoming webinar, participants will have the opportunity to explore how current trends and challenges are influencing drug development trajectories in the year 2026. This session aims to provide insights that can assist stakeholders in navigating uncertainty and making informed, strategic decisions.
TORONTO, March 11, 2026 /PRNewswire/ — The landscape for drug developers is increasingly defined by the necessity to adapt effectively to complexity, change, and escalating pressures within the development environment.
To gain a clearer understanding of industry responses, the PPD™ clinical research division of Thermo Fisher Scientific conducted a survey involving 150 leaders from biotech and pharmaceutical organisations globally as part of the fourth annual Pulse industry report. The findings from this year’s report highlight a significant trend: uncertainty is a key factor influencing decisions throughout research and development (R&D), affecting everything from strategic planning and investment to execution.
During this webinar, industry experts will delve into critical signals derived from the 2026 Pulse research and discuss their implications for navigating the rapidly evolving landscape of drug development. Attendees will be equipped with perspectives on how their peers are adapting their methodologies to maintain agility, manage risks, and foster innovation.
How are leading organisations making informed decisions despite unpredictable conditions? Registration for this webinar will provide insights that facilitate a clearer and more strategic approach to drug development in 2026.
Join experts from the PPD™ clinical research division of Thermo Fisher Scientific, including Daniel Jones, Vice President and General Manager of the Internal Medicine Business Unit, and Praveen Nadella, Head of Customer Insights & Intelligence, for the live webinar scheduled for Tuesday, March 31, 2026, at 11am EDT (5pm CEST/EU-Central).
For additional details or to register for this event, please visit Drug Development Insights: What New Industry Data Reveals for 2026.
About Xtalks
Xtalks — The Life Science Community™ empowers professionals across the pharmaceutical, biotechnology, medtech, healthcare, and research sectors by providing trusted knowledge and collaborative insights that drive the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks offers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities, and more, all designed to support informed decision-making in a rapidly evolving sector.
Each year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives, and industry thought leadership. Join our life science community to remain informed, connected, and prepared for future developments.
To learn more about Xtalks, visit www.xtalks.com.
For information regarding partnership opportunities with Xtalks to host your webinar, please visit https://xtalks.com/partner-with-us/.
For further inquiries, please contact Vera Kovacevic at Tel: +1 (416) 977-6555 x371 or via email at [email protected].
SOURCE Xtalks